IP Library Patent Application 16999640
Patent Application
App. No. 16/999,640

SYSTEMS AND METHODS FOR TRANSCATHETER AORTIC VALVE TREATMENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/999,640
Abstract

Devices and methods are configured to allow transcervical or subclavian access via the common carotid artery to the native aortic valve, and implantation of a prosthetic aortic valve into the heart. The devices and methods also provide means for embolic protection during such an endovascular aortic valve implantation procedure.

Claims (33)

1 . A method of treating an aortic valve of a heart, the method comprising:

forming a penetration at the neck of a patient in a wall of a common carotid artery;

introducing an arterial access sheath through the penetration, the arterial access sheath comprising a proximal end region, a distal end region, and an internal lumen extending between the proximal end region and the distal end region, the proximal end region coupled to a hemostatic device and the distal end region coupled to an embolic protection filter in a collapsed state configured for insertion to a vessel;

deploying the embolic protection filter from the collapsed state to a deployed state configured to deploy across a diameter of the vessel to capture embolic material flowing through the vessel to provide embolic protection;

inserting a guide wire across a native aortic valve; and

introducing a prosthetic valve through the arterial access sheath and deploying the prosthetic valve at or near the position of the native aortic valve.

2 . A method as in claim 1 , further comprising:

collapsing the embolic protection filter;

removing the arterial access sheath; and

closing the penetration.

3 . A method as in claim 2 , wherein the embolic protection filter is withdrawn or removed prior to removing the arterial access sheath.

4 . A method as in claim 1 , further comprising applying a closure device at a site of the penetration before introducing the arterial access sheath through the penetration.

5 . A method as in claim 4 , wherein the closure device comprises a suture-based closure device.

6 . A method as in claim 1 , wherein the vessel is the ascending aorta or a region of the aortic arch.

7 . A method as in claim 1 , further comprising occluding the common carotid artery.

8 . A method as in claim 7 , further comprising establishing blood flow from the common carotid artery such that blood flows into the internal lumen of the arterial access sheath.

9 . A method as in claim 8 , further the blood flows out a side opening located between the distal end and the proximal end of the arterial access sheath.

10 . A method as in claim 8 , wherein the blood flows into a shunt connected to the access sheath.

11 . A method as in claim 10 , further comprising fluidly connecting the shunt to a collection reservoir or a venous return site in the patient.

12 . A method as in claim 8 , further comprising regulating the rate of flow from the common carotid artery.

13 . A method as in claim 7 , further comprising applying aspiration to the artery through the access sheath.

14 . A method as in claim 13 , further comprising regulating a rate of the aspiration.

15 . A method as in claim 7 , wherein occluding the common carotid artery comprises inflating an occlusion balloon on the arterial access sheath.

16 . A method as in claim 1 , wherein the internal lumen of the arterial access sheath is sized and shaped to receive a valve delivery system configured to deliver the prosthetic valve into the heart through the arterial access sheath.

17 . A method as in claim 1 , wherein the embolic protection filter comprises an expandable frame and a filter material covering the frame.

18 . A method as in claim 17 , wherein the filter material is a woven textile material or a knitted textile material.

19 . A method as in claim 17 , wherein the filter material is a perforated polymer membrane.

20 . A method as in claim 17 , wherein the filter material has a porosity that is between 40 micron porosity and 300 micron porosity.

21 . A method as in claim 17 , wherein the expandable frame is formed of a spring material.

22 . A method as in claim 21 , wherein the spring material is stainless steel, Nitinol wire, or Nitinol ribbon.

23 . A method as in claim 17 , wherein the expandable frame is a loop having an expanded diameter between 12 mm and 30 mm.

24 . A method as in claim 17 , wherein the expandable frame is formed by a series of struts connected at one or both ends of the embolic protection filter.

25 . A method as in claim 1 , wherein the embolic protection filter has a cone shape or a closed-end tube shape.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2020
From: GARRISON, MICHI E.; CHOU, TONY M.; HYDE, GREGORY M.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 053578/0945 →